A Study of a PD-1/CTLA-4 Bispecific Antibody AK104 in Patients With Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT04220307 · COMPLETED
Trial details
- NCT number
- NCT04220307
- Sponsor
- Akeso
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-26
- Primary completion
- 2021-05-15
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.